EGFR epidermal growth factor

EGFR epidermal growth factor receptor GSH glutathione... [Pg.964]

EGFR epidermal growth factor receptor (cancer cell marker that is a target for anti-neoplastic therapy) ELISA enzyme-linked immunosorbent assay (measurement method)... [Pg.456]

EGFR Epidermal growth factor receptor PP2A Protein phosphatase, type 2A... [Pg.577]

EGFR (epidermal growth factor receptor) Plasma membrane At nuclear membrane by biochemical fractionization M. Musculus liver Yes (Schirmer et al. 2003 Klein et al. 2004)... [Pg.67]

Model I has been applied to a wide variety of drug responses, such as the reduction of fever (8, 20) or pain (19) by anti-inflammatory drugs, anticoagulant action of warfarin (3,9), reduction in blood sorbitol levels by inhibitors of aldose reductase (21), cortisol suppressive effects of corticosteroids (22), luteinizing hormone suppression by the synthetic hormone cetrorelix (23), reduction in the levels of tumoral phospho-EGFR (epidermal growth factor receptor) by cetuximab (24), inhibition of dihydrotestosterone (25), the suppression of T-lymphocyte influx into the blood by corticosteroids (26), and the acid-inhibitory effects of H2-receptor antagonists (27). [Pg.585]

EGFR Epidermal growth factor receptor ERK Extracellular signal-regulated kinase GSH Glutathione... [Pg.203]

CA cancer antigen, CD cluster of differentiation, MUC mucin, TAG tumor-associated glycoprotein, EGFR epidermal growth factor receptor, MAG mercaptoacetyltriglycine, EC ethylcysteinate, HYNIC hydrazine nicotinamide... [Pg.49]

ABBREVIATIONS CLL, chronic lymphocytic leukemia EGFR, epidermal growth factor receptor NSCLC, non-small cell lung cancer VEGF, vascular endothelial growth factor. [Pg.902]

ABBREVIATIONS ADCC, antibody-dependent cellular cytotoxicity CDC, complement-dependent cytotoxicity EGFR, epidermal growth factor receptor VOD, veno-occlusive disease. [Pg.903]

Dilute antibodies in PBS with 1% BSA and use as follows monoclonal anti-EGFR (epidermal growth factor receptor) at 1 80 anti-dp-ERK 1/2 (dual-phosphorylated ERK 1/2) 1 50 sheep antimouse IgG FITC conjugate 1 128 (F2266) and 1 250 (F2883), respectively. [Pg.90]

NHL non-Hodgkin s lymphoma CLL chronic lymphocytic leukemia AML acute myelogenous leukemia CRC colorectal cancer NSCLC non-small cell lung cancer EGFR epidermal growth factor receptor VEGF vascular endothehal growth factor. [Pg.334]